NUE vs SGMO · P/E 25, rev $19.89B vs rev $57.8M
Nucor Corp (NUE) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Nucor Corp (NUE) is a steel company listed on NYSE.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
NUE currently screens at market cap $57.53B and trailing P/E 25.1. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the NUE and SGMO stock pages for the full models.
Not investment advice.